Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Kunming Medical UniversityNo recent work listed

Hongjin Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2053-7441; OpenAlex author ID A5047452735. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

  1. Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12864-021-08137-5↗
  2. Transcriptome sequencing analysis reveals unique and shared antitumor effects of three statins in pancreatic cancer. First author DOI 10.3892/or.2020.7810↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juehua Yu · 2 shared papers, 2020–2021 · strength 0.23
  2. Xiaosong Zhu · 1 shared paper, 2021 · strength 0.13
  3. Shi‐He Liu · 1 shared paper, 2020 · strength 0.10
  4. Cheng Yeh Chen · 1 shared paper, 2020 · strength 0.10
  5. Yu Xu · 1 shared paper, 2020 · strength 0.10
  6. Kunhua Wang · 1 shared paper, 2020 · strength 0.10
  7. Lei Zou · 1 shared paper, 2020 · strength 0.10
  8. Francis Charles Brunicardi · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.